产品标题 产品货号 产品规格 厂家
Human Brain; Oligodendroglioma, anaplastic from ORIGENE TECHNOLOGIESCS6027925x5umORIGENE TECHNOLOGIES
Human brain protein 44-like (BRP44L) from ORIGENE TECHNOLOGIESTP30146120 ugORIGENE TECHNOLOGIES
Human brain-specific angiogenesis inhibitor 3 (BAI3) from ORIGENE TECHNOLOGIESTP72036310 ugORIGENE TECHNOLOGIES
Human Brain; Vascular malformation of brain from ORIGENE TECHNOLOGIESCS8122815x5umORIGENE TECHNOLOGIES
Human Brain; Vascular malformation of brain from ORIGENE TECHNOLOGIESCS6439345x5umORIGENE TECHNOLOGIES
Human branched chain amino-acid transaminase 1, cytosolic (BCAT1), transcript variant 1, full length from ORIGENE TECHNOLOGIESTP76065350 ugORIGENE TECHNOLOGIES
Human branched chain aminotransferase 1, cytosolic (BCAT1) from ORIGENE TECHNOLOGIESTP31922920 ugORIGENE TECHNOLOGIES
Human branched chain aminotransferase 2, mitochondrial (BCAT2), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESTP30062520 ugORIGENE TECHNOLOGIES
Human branched chain keto acid dehydrogenase E1, beta polypeptide (BCKDHB), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIESTP30805920 ugORIGENE TECHNOLOGIES
Human branched chain ketoacid dehydrogenase kinase (BCKDK), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIESTP30360120 ugORIGENE TECHNOLOGIES
Human BRCA2 and CDKN1A interacting protein (BCCIP), transcript variant B from ORIGENE TECHNOLOGIESTP30306120 ugORIGENE TECHNOLOGIES
Human BRCA1 associated protein (BRAP) from ORIGENE TECHNOLOGIESTP76034950 ugORIGENE TECHNOLOGIES
Human BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (BAP1) from ORIGENE TECHNOLOGIESTP30037820 ugORIGENE TECHNOLOGIES
Human breakpoint cluster region (BCR), transcript variant 2 from ORIGENE TECHNOLOGIESTP31324720 ugORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma, metastatic, consistent with breast primary from ORIGENE TECHNOLOGIESCS5297215x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma, metastatic, consistent with breast primary from ORIGENE TECHNOLOGIESCS6389645x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma, metastatic, consistent with breast primary (triple negative) from ORIGENE TECHNOLOGIESCS6211535x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast from ORIGENE TECHNOLOGIESCS5142375x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast from ORIGENE TECHNOLOGIESCS6238365x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast from ORIGENE TECHNOLOGIESCS6296065x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS7017105x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS7044885x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS7058285x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS7102625x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS7108785x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS7116705x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS8030075x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS8031635x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS8062775x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS8064985x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS8096155x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5029515x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5036825x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5052975x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5058835x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5092735x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5106665x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5141145x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5150955x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5172275x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5187265x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5208335x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5200165x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5209475x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5210575x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5221625x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5223665x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5230695x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5238805x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5270045x5umORIGENE TECHNOLOGIES
 |< < 2449 2450 2451 2452 2453 2454 2455 2456 2457 > >| 第 2452/6274 页